Frontiers in Pharmacology | Drugs Outcomes Research and Policies

Original Research

Published on 08 Feb 2024

Impacts of national volume-based drug procurement policy on the utilization and costs of antihypertensive drugs in a Chinese medicine hospital: an interrupted time series analysis of 5138 patients

in Drugs Outcomes Research and Policies

Lili Shang
Yan Cheng
Jifang Zhou
Yuqing Bao
Desong Kong
Ruijian Huang
Yanfei Chen
Hao Wang
Ning Gu
Aixia Ma

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1302154

3,228 views
2 citations

Review

Published on 08 Feb 2024

Effectiveness of perindopril/amlodipine fixed-dose combination in the treatment of hypertension: a systematic review

in Drugs Outcomes Research and Policies

Truong Van Dat
Vo Linh Tu
Le Nguyen Anh Thu
Nguyen Nhat Anh Quang
Van Binh
Nguyen Thi Quynh Nga
Duong Hoang Loc
Tran Thi Hong Nguyen
Dao Ngoc Hien Tam
Hong-Han Huynh

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1156655

10,028 views
3 citations

Perspective

Published on 07 Feb 2024

Enhancing the clinical research workforce: a collaborative approach with human resources

in Drugs Outcomes Research and Policies

Denise C. Snyder
Heather Gaudaur
Mark Marchant
Laura Viera
Andrea McCubbin
William Verble
Angela Mendell
Christine Gilliam

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1295155

3,226 views
3 citations

Review

Published on 07 Feb 2024

Esketamine combined with sufentanil versus sufentanil in patient-controlled intravenous analgesia: a meta-analysis

in Drugs Outcomes Research and Policies

Manman Yao
Baoxia Fang
Jinguo Yang
Peng Chen
Fuchao Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1247646

4,095 views
7 citations

Original Research

Published on 05 Feb 2024

Cost-effectiveness of tumor-treating fields plus standard therapy for advanced non-small cell lung cancer progressed after platinum-based therapy in the United States

in Drugs Outcomes Research and Policies

Wentao Tian
Jiaoyang Ning
Liu Chen
Yu Zeng
Yin Shi
Gang Xiao
Shuangshuang He
Guilong Tanzhu
Rongrong Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1333128

3,852 views
4 citations

Original Research

Published on 31 Jan 2024

A real-world disproportionality analysis of mesalazine data mining of the public version of FDA adverse event reporting system

in Drugs Outcomes Research and Policies

Mingdi Liu
Liting Gu
Yuning Zhang
Honglan Zhou
Yishu Wang
Zhi-Xiang Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1290975

3,756 views
11 citations

Original Research

Published on 29 Jan 2024

Real world drug treatment models for pregnancy complicated with urinary tract infection in China from 2018 to 2022: a cross-section analysis

in Drugs Outcomes Research and Policies

Jing Jin
Changyan Li
Yuqing He
Jiaqian Pan
JiaLei Zhu
Jing Tang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1349121

3,225 views
2 citations

Original Research

Published on 29 Jan 2024

Impact of a pharmacist-led educational intervention on knowledge, attitude, and practice toward the rational use of antibiotics among healthcare workers in a secondary care hospital in Punjab, Pakistan

in Drugs Outcomes Research and Policies

Shairyar Afzal
Farman Ullah Khan
Muhammad Tahir Aqeel
Matti Ullah
Mishal Bajwa
Masoom Akhtar
Muhammad Majid

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1327576

3,904 views
11 citations

Original Research

Published on 29 Jan 2024

Ethics of access to newly approved expensive medical treatments: multi-stakeholder dialogues in a publicly funded healthcare system

in Drugs Outcomes Research and Policies

Charlotte H. C. Bomhof
Jilles Smids
Sybren Sybesma
Maartje Schermer
Eline M. Bunnik

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1265029

3,043 views
1 citation

Original Research

Published on 26 Jan 2024

Applying the estimand and target trial frameworks to external control analyses using observational data: a case study in the solid tumor setting

in Drugs Outcomes Research and Policies

Letizia Polito
Qixing Liang
Navdeep Pal
Philani Mpofu
Ahmed Sawas
Olivier Humblet
Kaspar Rufibach
Dominik Heinzmann

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1223858

5,750 views
4 citations

Original Research

Published on 25 Jan 2024

Strengths and opportunities to clinical trial enrollment among BIPOC, rural dwelling patients in the northwest United States: a retrospective study

in Drugs Outcomes Research and Policies

Jamie M. Nelson
Elizabeth Johnson
Becky Kiesow
Bernadette McCrory
Jiahui Ma

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1309072

2,304 views
1 citation

Original Research

Published on 25 Jan 2024

Social and cultural determinants of antibiotics prescriptions: analysis from a public community health centre in North India

in Drugs Outcomes Research and Policies

Arunima Mukherjee
Rashmi Surial
Sundeep Sahay
Yogita Thakral
Amandeep Gondara

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1277628

5,414 views
7 citations

Original Research

Published on 24 Jan 2024

A real-world pharmacovigilance study of FDA adverse event reporting system events for diazepam

in Drugs Outcomes Research and Policies

Weizhen He
Yang Wang
Kaiqin Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1278442

4,023 views
3 citations

Original Research

Published on 24 Jan 2024

Clinical relevance and implementation into daily practice of pharmacist-prescribed medication for the management of minor ailments

in Drugs Outcomes Research and Policies

Noelia Amador-Fernández
Irina Botnaru
Samuel Sebastian Allemann
Véronique Kälin
Jérôme Berger

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1256172

3,131 views
2 citations

Original Research

Published on 24 Jan 2024

The differential impact of a 6-versus 12-month pharmacist-led interprofessional medication adherence program on medication adherence in patients with diabetic kidney disease: the randomized PANDIA-IRIS study

in Drugs Outcomes Research and Policies

Carole Bandiera
Jennifer Dotta-Celio
Isabella Locatelli
Dina Nobre
Grégoire Wuerzner
Menno Pruijm
Faiza Lamine
Michel Burnier
Anne Zanchi
Marie Paule Schneider

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1294436

2,187 views
3 citations

Original Research

Published on 23 Jan 2024

Effectiveness and economic evaluation of rhTPO and rhIL-11 in the treatment of cancer therapy induced thrombocytopenia based on real-world research

in Drugs Outcomes Research and Policies

Fa-Min Gong
Fu-Yue Liu
Xue Ma
Song-Tao Ma
Hong-Tao Xiao
Gang Jiang
Ting-Ting Qi

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1288964

2,260 views
1 citation